Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
An audible gasp rippled through the room after the tally of the votes was announced for BPC-157
TB-500 (thymosin 4) is studied for cell migration and tissue repair mechanisms, again predominantly in preclinical settings
Science and medicine just dont move that fast. Some clinics have also promised dramatic results from BPC-157
The efficacy of these products has not been confirmed by FDA-approved research
No lethal dose identified at doses up to 20 mg/kg in animal studies No organ toxicity observed across multiple organ systems Negative mutagenicity testing across standard assays No teratogenic effects in pregnancy studies Limited long-term human data beyond 6 weeks Theoretical Considerations The primary theoretical concern relates to BPC-157s angiogenic properties
US$ 26.25
US$ 26.62
US$ 27.20
US$ 28.24
US$ 24.44
US$ 21.31
US$ 27.00
US$ 22.39
US$ 20.21
US$ 29.75
US$ 29.00
US$ 20.75
US$ 20.27
US$ 24.23
